• Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

  • 2022/07/19
  • 再生時間: 10 分
  • ポッドキャスト

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

  • サマリー

  • Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.

    Read the full article:
    Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.

Read the full article:
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenomaに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。